| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.0M | -9.4% |
| Cost of Revenue | $22.0M | -17.9% |
| Gross Profit | $13.0M | +10.1% |
| R&D Expense | $100K | +0.0% |
| SG&A Expense | $19.0M | -22.5% |
| Operating Income | -$6.0M | +71.8% |
| Interest Expense | $467K | -65.5% |
| Pre-tax Income | -$159K | +99.3% |
| Income Tax | $9K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | -31.2% |
| Accounts Receivable | $5.4M | +23.4% |
| Inventory | $3.9M | -41.5% |
| Current Assets | $15.0M | -7.6% |
| Total Assets | $15.8M | -5.6% |
| Current Liabilities | $7.1M | -47.8% |
| Long-term Debt | $2.4M | -54.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.4M | -4591.8% |
| Capital Expenditures | $41K | +127.8% |
| Investing Cash Flow | -$2.3M | — |
| Financing Cash Flow | $5.2M | +202.4% |
| Free Cash Flow | -$4.4M | -5667.1% |
| +350.0% |
| Net Income | -$168K | +99.3% |
| EPS (Basic) | -$0.10 | +99.7% |
| EPS (Diluted) | -$0.10 | +99.7% |
| Total Liabilities |
| $7.2M |
| -48.0% |
| Stockholders' Equity | $8.6M | +190.4% |